Oral sirolimus for verrucous venous malformation: a cohort study

"Long-term sirolimus in verrucous venous malformation cohort study and ponatinib as a potential therapeutic strategy for MAP3K3-mutatant-patient in vitro" Supplemental Data for JAAD Brief Report.西罗莫司治疗疣状静脉畸形的长期队列研究及普纳替尼作为MAP3K3突变患者潜在的体外治疗策略——《美国皮肤病学会杂志（JAAD）》短篇报告补充数据